NUVB – nuvation bio inc. class a (US:NASDAQ)
Stock Stats
News
Nuvation Bio (NUVB) Generates $62.9M Annual Revenue Following Successful Erozi Launch [Yahoo! Finance]
Nuvation Bio Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
Nuvation Bio Transitions To Commercial Stage With Iptrozi And Safusidenib Progress [Yahoo! Finance]
Nuvation Bio Stock Up 130% This Past Year as One Fund Discloses $3 Million Buy [Yahoo! Finance]
Nuvation Bio (NUVB) had its price target lowered by UBS Group AG from $10.00 to $7.00. They now have a "neutral" rating on the stock.
Form 4 Nuvation Bio Inc. For: Feb 27 Filed by: Liu Dongfang
Form 4 Nuvation Bio Inc. For: Feb 27 Filed by: Makunje Moses
Form 4 Nuvation Bio Inc. For: Feb 27 Filed by: Wentworth Kerry
Form 4 Nuvation Bio Inc. For: Feb 27 Filed by: Sjogren Colleen
Form 4 Nuvation Bio Inc. For: Feb 27 Filed by: Sauvage Philippe
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.